Angiotensin-(1–7) Antagonist A-779 Attenuates the Potentiation of Bradykinin by Captopril in Rats

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-200405000-00011PMID 15071356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• The role of regulated CFTR trafficking in epithelial secretion.

  2003cited by this paper
• Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.

  2003cited by this paper
• Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.

  2003cited by this paper
• Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR.

  2003cited by this paper
• Roles of the Two Active Sites of Somatic Angiotensin‐Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin Insights From Selective Inhibitors

  2003cited by this paper
• The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.

  2003cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002influential reference
• AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

  2002cited by this paper
• Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade

  2001cited by this paper
• Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice

  2001cited by this paper
• Angiotensin(1–7) potentiates bradykinin-induced vasodilatation in man

  2001cited by this paper
• Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension

  2001cited by this paper
• Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm

  2001cited by this paper
• Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.

  2001cited by this paper
• Baroreflex Improvement in SHR After ACE Inhibition Involves Angiotensin-(1-7)

  2001cited by this paper
• Potentiation of Bradykinin by Angiotensin-(1-7) on Arterioles of Spontaneously Hypertensive Rats Studied In Vivo

  2001cited by this paper
• Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.

  2000cited by this paper
• Angiotensin-(1-7): an update.

  2000cited by this paper
• Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.

  1999cited by this paper
• Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides.

  1999cited by this paper
• Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.

  1999cited by this paper
• Potentiation of Bradykinin Actions by ACE Inhibitors.

  1999cited by this paper
• Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.

  1998influential reference
• Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.

  1998cited by this paper
• Interaction of bradykinin and angiotensin‐(1–7) in the central modulation of the baroreflex control of the heart rate

  1998cited by this paper
• N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

  1998cited by this paper
• Counterregulatory actions of angiotensin-(1-7).

  1997influential reference
• ACE inhibitor potentiation of bradykinin‐induced venoconstriction

  1997cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.

  1997cited by this paper
• Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats.

  1997cited by this paper
• Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.

  1996cited by this paper
• [Cardioactive hormones: bradykinin].

  1996cited by this paper
• Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.

  1996cited by this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.

  1995cited by this paper
• Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

  1994cited by this paper
• Nephrectomy, converting enzyme inhibition, and angiotensin peptides.

  1993cited by this paper
• Differential baroreceptor reflex modulation by centrally infused angiotensin peptides.

  1992cited by this paper
• Converting Enzyme Activity and Angiotensin Metabolism in the Dog Brainstem

  1988influential reference
• Crossover design to test antihypertensive drugs with self-recorded blood pressure.

  1988cited by this paper

• Unlocking the potential of the ACE2/Ang‐(1–7)/Mas Axis in liver diseases: From molecular mechanisms to translational applications

  2025cites this paper
• Clinical significance of intervention in the renin-angiotensin-aldosterone-apelinergic system.

  2025cites this paper
• The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress

  2021cites this paper
• Novel phthalamide derivatives as antihypertensive agents: rapid and clean synthesis, in silico and in vivo evaluation

  2019cites this paper
• 1 Up-Regulation of Renin-Angiotensin System in Diabetes and Hypertension : Implications on the Development of Diabetic Nephropathy

  2018cites this paper
• Vasodilator Effect of Angiotensin-(1-7) on Vascular Coronary Bed of Rats: Role of Mas, ACE and ACE2.

  2017cites this paper
• Pathogenesis of Macrovascular Complications in Diabetes

  2016cites this paper
• Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats

  2016cites this paper
• Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney

  2016cites this paper
• ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.

  2016cites this paper
• Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure

  2015cites this paper
• ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension

  2015cites this paper
• Angiotensin-(1-7) Augments Endothelium-dependent Relaxations of Porcine Coronary Arteries to Bradykinin by Inhibiting Angiotensin-Converting Enzyme 1

  2014cites this paper
• Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction

  2014cites this paper
• Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

  2013cites this paper
• Protective Role of the ACE2/Ang-(1–9) Axis in Cardiovascular Remodeling

  2012cites this paper
• The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease

  2012cites this paper
• Up-Regulation of Renin-Angiotensin System in Diabetes and Hypertension: Implications on the Development of Diabetic Nephropathy

  2012cites this paper
• The Pathogenesis of Macrovascular Complications Including Atherosclerosis in Diabetes

  2010cites this paper
• ERK1/2 Mediated The Vasodilatation of Apelin-13 on Vascular Rings of Spontanously Hypertensive Rat in vitro *: ERK1/2 Mediated The Vasodilatation of Apelin-13 on Vascular Rings of Spontanously Hypertensive Rat in vitro *

  2010cites this paper
• Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

  2010cites this paper
• Therapeutic Perspectives of Angiotensin-(1-7) in the Treatment of Cardiovascular Disease

  2009cites this paper
• Renin-angiotensin system in the pathogenesis of liver fibrosis.

  2009cites this paper
• Angiotensin-(1–7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

  2009cites this paper
• Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

  2009cites this paper
• Participation of kallikrein-kinin system in different pathologies.

  2008cites this paper
• The renin–angiotensin system and diabetes: An update

  2008cites this paper
• Efeitos cardiovasculares induzidos por antagonistas angiotensinérgicos no bulbo ventrolateral de ratos com hipertensão renovascular.

  2008cites this paper
• Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression.

  2008cites this paper
• Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.

  2008cites this paper
• Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats.

  2008cites this paper
• Angiotensin-(1–7) and the renin–angiotensin system

  2007cites this paper
• Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy

  2007cites this paper
• A novel peptide from the ACEI/BPP-CNP precursor in the venom of Crotalus durissus collilineatus.

  2006cites this paper
• Angiotensin, bradykinin and the endothelium.

  2006cites this paper
• Avaliação do papel fisiopatológico da Angiotensina-(1-7) em modelo experimental de fibrose hepática

  2006cites this paper
• Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies

  2006cites this paper
• Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.

  2006cites this paper
• Cardiovascular actions of angiotensin-(1-7).

  2005cites this paper
• Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs

  2005cites this paper
• Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.

  2005cites this paper
• Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney

  2004cites this paper